Thomas Meyer

Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland.

Altamira Pharma GmbH manufactures pharmaceutical products. The private company is based in Zuchwil, Switzerland. The CEO of the Swiss company is Thomas Meyer.

Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland.

Part of Altamira Therapeutics Ltd., Altamira Medica AG is a Swiss company that offers bentrio, an OTC drug-free nasal spray designed to protect against airborne allergens and viruses. The private company is based in Zug, Switzerland, and Thomas Meyer has been the CEO of the company since 2020. The spray forms a protective gel layer on the nasal mucosa to prevent contact with allergens or virus particles and helps to bind and discharge them. Altamira Medica strives to empower people to live with confidence and control when it comes to protection against allergens.

Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland.

Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland.